SCHEMBL19275993

SCHEMBL19275993

c1ccc(-c2nc(-c3ccc(-n4c5ccccc5c5ccccc54)cc3)cc(-c3cccnc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.49
▸ DHODH Q02127 1/20 0.48
▸ MAPT P10636 5/20 0.43
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NTSR1 P30989 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ CYP2C9 P11712 4/20 0.43
▸ CYP3A4 P08684 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ CLK4 Q9HAZ1 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ G6PD P11413 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ USP8 P40818 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397646 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853546 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853564 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853486 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853561 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853693 0.96 DHODH (0.50) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL19397640 0.95 CYP19A1 (0.49) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853490 0.93 DHODH (0.45) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL17853607 0.92 DHODH (0.46) CYP19A1DHODHMAPTMEN1KMT2A
SCHEMBL26431892 0.92 CYP19A1 (0.44) CYP19A1DHODHMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed
US-20170244044-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-24 — — US disclosed
US-20170244044-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-08-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 CYP19A1 936/4885DHODH 3858/4885MAPT 1926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback